Company intelligence / Profile preview

Prime Therapeutics

Eagan, Minnesota, United States

Ownership: Private
Employees: ~7000
Development stage: Other

Overview

Prime Therapeutics is a leading pharmacy benefit manager (PBM) owned by 19 Blue Cross and Blue Shield plans. The company provides a comprehensive suite of pharmacy benefit management services, including claims processing, formulary management, and specialty pharmacy services through its Magellan Rx Management division. Prime Therapeutics focuses on integrating medical and pharmacy data to improve health outcomes and reduce the total cost of care for its members. Serving millions of people across the United States, the company emphasizes transparency and clinical excellence in its service delivery.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Blue Cross and Blue Shield AssociationWalgreensCapital Rx

Beyond the preview

Go deeper on Prime Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prime Therapeutics.

Explore the full profile